Septulus, a novel cardiac surgery device
| Reference number | |
| Coordinator | Septulus AB |
| Funding from Vinnova | SEK 1 986 721 |
| Project duration | July 2016 - August 2018 |
| Status | Completed |
Important results from the project
To develop a minimally invasive device for treating hypertrophic obstructive cardiomyopathy (HOCM) of the heart.
Expected long term effects
During the Project we have been able to develop and test a device in an animal model with success.
Approach and implementation
We also performed market research by meeting with Investors, key opinion leaders and industry representatives,